FindTrial
Sign In

Study on the application effect of 2% lidocaine nebulized inhalation in patients undergoing regular gastroscopy examination

Study on the application effect of 2% lidocaine nebulized inhalation in patients undergoing regular gastroscopy examination

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088125
Enrollment
Unknown
Registered
2024-08-12
Start date
2024-01-23
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Lidocaine aerosol inhalation group:Lidocaine nebulized inhalation for 10 minutes
Lidocaine gel oral administration group:take lidocaine gel for 3 mins by mouth

Sponsors

Xuanwu Hospital of Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ? Subjects who meet the indications for regular gastroscopy examination; ? Subjects who voluntarily participate in the enrollment are between the ages of 18 and 70

Exclusion criteria

Exclusion criteria: ? Subjects who are allergic to lidocaine; ? Subjects with coronary heart disease; ? Subjects with sensory impairments; ? Subjects with oral and pharyngeal diseases; ? Subjects with a history of hypotension have a blood pressure of (90/60mmHg); ? Subjects who take sedatives for a long time;

Design outcomes

Primary

MeasureTime frame
Tolerance score of subjects in regular gastroscopy examination;—

Secondary

MeasureTime frame
Difficulty score of gastroscopy insertion;—

Countries

China

Contacts

Public ContactQIU GUANG WEI

Xuanwu Hospital of Capital Medical University

qiuqiu2716@sina.com+86 135 2054 8652

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026